Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Deferred Taxes (2020 - 2026)

Neurocrine Biosciences filings provide 6 years of Deferred Taxes readings, the most recent being $48.2 million for Q4 2025.

  • On a quarterly basis, Deferred Taxes rose 253.99% to $48.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $165.4 million, a 234.36% increase, with the full-year FY2025 number at $165.4 million, up 234.36% from a year prior.
  • Deferred Taxes hit $48.2 million in Q4 2025 for Neurocrine Biosciences, down from $168.3 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $168.3 million in Q3 2025 to a low of -$41.5 million in Q2 2023.
  • Median Deferred Taxes over the past 5 years was -$4.4 million (2021), compared with a mean of $450000.0.
  • Biggest five-year swings in Deferred Taxes: crashed 10433.33% in 2023 and later surged 582.23% in 2025.
  • Neurocrine Biosciences' Deferred Taxes stood at -$4.7 million in 2021, then surged by 387.23% to $13.5 million in 2022, then skyrocketed by 52.59% to $20.6 million in 2023, then crashed by 251.94% to -$31.3 million in 2024, then surged by 253.99% to $48.2 million in 2025.
  • The last three reported values for Deferred Taxes were $48.2 million (Q4 2025), $168.3 million (Q3 2025), and -$37.4 million (Q2 2025) per Business Quant data.